Marjorie Green is a seasoned clinical investigator and drug developer, currently serving as Senior Vice President and Head of Oncology Development at Merck since 2024. With over 20 years of expertise in clinical trials and patient care, Marjorie previously held the position of Senior Vice President at Seattle Genetics from 2020 to 2023, and has significant leadership experience at Genentech, where they directed multiple phase III trials. Marjorie is also a member of the Board of Directors at NeoGenomics Laboratories, contributing to strategic oversight in oncology development. They completed a Medical Oncology Fellowship at the University of Texas M. D. Anderson Cancer Center from 1998 to 2001.
This person is not in the org chart
This person is not in any teams
This person is not in any offices